Key biomarkers in type 2 diabetes patients: a systematic review
Le TN, Bright R, Truong VK, et al.
Diabetes Obes Metab. Pub. online 2 Oct 2024.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Associations of metabolic syndrome and its components with sarcopenia, and the mediating role of insulin resistance: Findings from NHANES database
Li M, Ji R, Liu X, Wu Y
BMC Endocr Disord. Pub. online 30 Sep 2024.
Leggi
Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies
Nabrdalik K, Hendel M, Irlik K, et al.
BMC Endocr Disord. Pub. online 30 Sep 2024.
Leggi
Associations between weight self-stigma and healthy diet and physical activity among adults with type 2 diabetes: Cross-sectional results from the second Diabetes MILES – Australia (MILES-2) study
Manallack S, Holloway EE, Pouwer F, et al.
Diabet Med. Pub. online 30 Sep 2024.
Leggi
An evaluation of how exercise position statement guidelines are being used in the real world in type 1 diabetes: Findings from the type 1 diabetes exercise initiative (T1DEXI)
Jacobs PG, Chase Marak M, Calhoun P, et al.
Diabetes Res Clin Pract. Pub. online 27 Sept 2024.
Leggi
Estimated long-term benefits of finerenone in heart failure: a prespecified secondary analysis of the FINEARTS-HF randomized clinical trial
Vaduganathan M, Claggett BL, Desai AS, et al.
JAMA Cardiol. Pub. online 27 Sept 2024.
Leggi
Effects of the non-steroidal MRA finerenone with and without concomitant SGLT2 inhibitor use in heart failure
Vaduganathan M, Claggett BL, Kulac IJ, et al.
Circulation. Pub. online 28 Sept 2024.
Leggi
Ambulatory blood pressure monitoring and vascular complications in patients with type 1 diabetes mellitus – Systematic review and meta-analysis of observational studies
Costa Hoffmeister M, Hammel Lovison V, Priesnitz Friedrich E, da Costa Rodrigues T
Diabetes Res Clin Pract. Pub. online 27 Sept 2024.
Leggi
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Kosiborod MN, Windsor SL, Vardeny O, et al.
Lancet Diabetes Endocrinol. 2024;12(10):725-734.
Leggi
Effects of glucagon-like peptide-1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta-analysis of randomized controlled trials
Karakasis P, Koufakis T, Patoulias D, et al.
Diabetes Obes Metab. Pub. online 30 Sept 2024.
Leggi